In-hospital outcomes of TAVR patients with a bundle branch block: Insights from the National Inpatient Sample 2011-2018.
Bundle Branch Blocks
TAVI
TAVR
transcatheter aortic valve implantation
transcatheter aortic valve replacement
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
18
04
2022
received:
23
12
2021
accepted:
05
07
2022
pubmed:
18
7
2022
medline:
14
9
2022
entrez:
17
7
2022
Statut:
ppublish
Résumé
Data on the outcomes following transcatheter aortic valve replacement (TAVR) in patients with a bundle branch block (BBB) remains limited. We studied the outcomes of TAVR patients with a BBB from the National Inpatient Sample (NIS) database between 2011 and 2018 using ICD-9-CM and ICD-10-CM codes. Between 2011 and 2018, 194,237 patients underwent TAVR, where 1.7% (n = 3,232) had a right BBB (RBBB) and 13.7% (n = 26,689) had a left BBB (LBBB). Patients with a RBBB and LBBB had a higher rate of new permanent pacemaker (PPM) implantation (31.5% - RBBB, 15.7% LBBB vs. 10.2% - no BBB). RBBB was associated with a significantly longer median length of stay (5 days) and total hospitalization cost ($53,669) compared with LBBB (3 days and $47,552) and no BBB (3 days and $47,171). Trend analysis revealed lower rates of PPM implantation and reduced lengths of stay and costs across all comparison groups. In conclusion, patients undergoing TAVR with a BBB are associated with higher new rates of PPM implantation. RBBB is the strongest independent predictor for new PPM implantation following TAVR. Rates of new PPM implantation in TAVR patients with and without a BBB have improved over time including reductions in length of stay and hospital costs. Further study is needed to reduce the risks of PPM implantation in TAVR patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
424-436Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Steinberg BA, Harrison JK, Frazier-Mills C, Hughes GC, Piccini JP. Cardiac conduction system disease after transcatheter aortic valve replacement. Am Heart J. 2012;164:664-671. doi:10.1016/j.ahj.2012.07.028
Grube E, Sinning J-M. The “big five” complications after transcatheter aortic valve replacement: do we still have to be afraid of them? JACC Cardiovasc Interv. 2019;12:370-372. doi:10.1016/j.jcin.2018.12.019
Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017;136:1049-1069. doi:10.1161/CIRCULATIONAHA.117.028352
Winter M-P, Bartko P, Hofer F, et al. Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies. Sci Rep. 2020;10:15568. doi:10.1038/s41598-020-72453-1
Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64:129-140. doi:10.1016/j.jacc.2014.04.033
Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of New-Onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9:e003635. doi:10.1161/CIRCINTERVENTIONS.115.003635
Sammour Y, Krishnaswamy A, Kumar A, et al. Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2021;14:115-134. doi:10.1016/j.jcin.2020.09.063
Agency for Healthcare Research and Quality. Overview of the national (nationwide) inpatient sample (NIS). Rockville: AHRQ; 2019. https://www.hcup-us.ahrq.gov/nisoverview.jsp#about
Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2000-2011. Agency for Healthcare Research and Quality, Rockville MD. 2013.
Ullah W, Zahid S, Zaidi SR, et al. Predictors of permanent pacemaker implantation in patients undergoing transcatheter aortic valve replacement - a systematic review and meta-analysis. J Am Heart Assoc. 2021;10:e020906. doi:10.1161/JAHA.121.020906
Saint Croix GR, Lacy SC, Hrachian H, Beohar N. Clinical impact of preexisting right bundle branch block after transcatheter aortic valve replacement: A systematic review and meta-analysis. J Interv Cardiol. 2020;2020:1789516. doi:10.1155/2020/1789516
Auffret V, Webb JG, Eltchaninoff H, et al. Clinical impact of baseline right bundle branch block in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10:1564-1574. doi:10.1016/j.jcin.2017.05.030
Watanabe Y, Kozuma K, Hioki H, et al. Pre-Existing right bundle branch block increases risk for death after transcatheter aortic valve replacement with a balloon-expandable valve. JACC Cardiovasc Interv. 2016;9:2210-2216. doi:10.1016/j.jcin.2016.08.035
van Gils L, Tchetche D, Lhermusier T, et al. Transcatheter heart valve selection and permanent pacemaker implantation in patients with pre-existent right bundle branch block. J Am Heart Assoc. 2021;6:e005028. doi:10.1161/JAHA.116.005028
Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-1798. doi:10.1056/NEJMoa1400590
Kotsakou M, Kioumis I, Lazaridis G, et al. Pacemaker insertion. Ann Transl Med. 2015;3:42. doi:10.3978/j.issn.2305-5839.2015.02.06
Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement. Circulation. 2017;136:1049-1069. doi:10.1161/CIRCULATIONAHA.117.028352
De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the pacemaker rate after transition from edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv. 2016;9:805-813. doi:10.1016/j.jcin.2015.12.023
Tang G, Zaid S, Michev I, et al. “Cusp-Overlap” view simplifies Fluoroscopy-guided implantation of self-expanding valve in transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:1663-1665. doi:10.1016/j.jcin.2018.03.018
Sammour Y, Banerjee K, Kumar A, et al. Systematic approach to high implantation of SAPIEN-3 valve achieves a lower rate of conduction abnormalities including pacemaker implantation. Circ Cardiovasc Interv. 2021;14:e009407. doi:10.1161/CIRCINTERVENTIONS.120.009407
Mirza M, Strunets A, Shen W-K, Jahangir A. Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med. 2012;28:555-573. doi:10.1016/j.cger.2012.08.005
Cramariuc D, Rogge BP, Lønnebakken MT, et al. Sex differences in cardiovascular outcome during progression of aortic valve stenosis. Heart. 2015;101:209-214. doi:10.1136/heartjnl-2014-306078
Hayashida K, Morice M-C, Chevalier B, et al. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol. 2012;59:566-571. doi:10.1016/j.jacc.2011.10.877
Baan J Jr., Yong ZY, Koch KT, et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J. 2010;159:497-503. doi:10.1016/j.ahj.2009.12.009
Kawsara A, Sulaiman S, Alqahtani F, et al. Temporal trends in the incidence and outcomes of pacemaker implantation after transcatheter aortic valve replacement in the United States (2012-2017). J Am Heart Assoc. 2020;9:e016685. doi:10.1161/JAHA.120.016685
Ullah W, Zahid S, Hamzeh I, Birnbaum Y, Virani SS, Alam M. Trends and predictors of transcatheter aortic valve implantation related In-Hospital mortality (from The National inpatient sample database. Am J Cardiol. 2020;143:97-103. doi:10.1016/j.amjcard.2020.12.031
Sathananthan J, Lauck S, Webb JG, Wood DA. Minimalist transcatheter aortic valve replacement: the right pathway forward. Interv Cardiol Clin. 2018;7:435-443. doi:10.1016/j.iccl.2018.07.001
Fischer Q, Himbert D, Webb JG, et al. Impact of preexisting left bundle branch block in transcatheter aortic valve replacement recipients. Circ Cardiovasc Interv. 2018;11:e006927. doi:10.1161/CIRCINTERVENTIONS.118.006927
Massoullié G, Bordachar P, Ellenbogen KA, et al. New-Onset left bundle branch block induced by transcutaneous aortic valve implantation. Am J Cardiol. 2016;117:867-873. doi:10.1016/j.amjcard.2015.12.009
Bussink BE, Holst AG, Jespersen L, Deckers JW, Jensen GB, Prescott E. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study. Eur Heart J. 2013;34:138-146. doi:10.1093/eurheartj/ehs291
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695-1705. doi:10.1056/NEJMoa1814052